Heparin Monitoring: The Confusion Continues
Open Access
- 1 November 1999
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 19 (11) , 1240-1242
- https://doi.org/10.1592/phco.19.16.1240.30881
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Correlation of Activated Clotting Time and Activated Partial Thromboplastin Time to Plasma Heparin ConcentrationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Monitoring Unfractionated Heparin Therapy with Antifactor Xa Activity Results in Fewer Monitoring Tests and Dosage Changes than Monitoring with the Activated Partial Thromboplastin TimePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Two Instruments to Determine Activated Partial Thromboplastin Time: Implications for Heparin MonitoringPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Problems with monitoring heparin anticoagulation.Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Heparin and Low-Molecular-Weight HeparinChest, 1998
- Inability of the Activated Partial Thromboplastin Time to Predict Heparin LevelsArchives of internal medicine (1960), 1997
- Monitoring Therapy with LMW Heparin: A Comparison of Three Chromogenic Substrate Assays and the Heptest Clotting AssayPathophysiology of Haemostasis and Thrombosis, 1990
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Management of Heparin TherapyNew England Journal of Medicine, 1975